InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,221.55
(
0.00%
)
US TECH 100
17,756.00
(
0.19%
)
Dow Jones
39,437.98
(
0.02%
)
Brent Oil
81.95
(
-1.52%
)
Bitcoin
61,432.61
(
-2.34%
)
Post# of 320
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

mlkrborn

Send PM Follow Ignore
Followers 40
Posts 7682
Boards Moderated 1
Alias Born 01/04/2006

mlkrborn

Re: None

Monday, 07/30/2012 6:41:26 PM

Monday, July 30, 2012 6:41:26 PM

Post# of 320
Biovest advances process seeking European Marketing Approval for BiovaxID personalized lymphoma vaccine (BVTI) 0.41 0.00 : Co announced that the European Medicines Agency (EMA) has notified Biovest regarding the official designation of the Rapporteur and Co-Rapporteur for BiovaxID, a personalized cancer vaccine for the treatment of follicular non-Hodgkin's lymphoma.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up